全球肾脏卫生保健状况评估
该研究为国际肾脏病学会于2016年5月至9月对130个附属国家进行的问卷调查,旨在收集各国肾脏护理准备度、能力和应答信息。共125个国家(96%)回复,代表全球约93%(68亿)人口。结果显示各国在服务提供、筹资、人力、信息系统和领导治理方面差异巨大:全球95%、76%、75%的国家分别有血液透析、腹膜透析和肾移植设施,而非洲仅94%、45%、34%;基层始终可检测血肌酐估算eGFR和蛋白尿的国家仅18%和8%;急性肾损伤和非透析CKD登记系统分别仅7%和8%的国家可用。结论认为区域间和区域内差异显著,服务与人力存在重要缺口,调查结果可能有助于改善全球肾脏护理质量。
要点
- 全球125/130个国家回复调查,覆盖约93%(68亿)世界人口,肾脏护理能力区域差异显著。
- 全球119(95%)、95(76%)、94(75%)个国家分别具备血液透析、腹膜透析和肾移植设施;非洲相应为33(94%)、16(45%)、12(34%)。
- 基层始终可检测血肌酐估算eGFR和蛋白尿的国家分别仅21(18%)和9(8%)。
- 血液透析、腹膜透析和肾移植服务由公共资金免费提供的国家分别为50(42%)、48(51%)、46(49%)。
- 急性肾损伤和透析前CKD登记系统可用国家分别仅8(7%)和9(8%);国际AKI和CKD指南可及国家分别为52(45%)和62(52%)。
适用人群与场景
- 国际肾脏病学会附属的130个国家,由各国和区域肾脏病领导层通过ISN确定国家肾脏病学会领导、政策制定者和患者组织代表等关键知情人。
研究设计与关键结果
- 研究类型:问卷调查;2016年5月至9月由国际肾脏病学会对130个附属国家进行调查,125个国家回复(96%),共289/337名个人回复(85.8%,中位每国2名回复者,四分位间距1-3),代表全球73亿人口中约93%(68亿)。
- 全球119(95%)、95(76%)、94(75%)个国家分别具备血液透析、腹膜透析和肾移植设施;非洲分别为33(94%)、16(45%)、12(34%)。
- 基层慢性肾脏病监测中,血肌酐估算eGFR和蛋白尿检测始终可及的国家分别仅21(18%)和9(8%)。
- 血液透析、腹膜透析和肾移植服务由公共资金资助且在服务点免费提供的国家分别为50(42%)、48(51%)、46(49%)。
- 肾脏病医生数量可变,在非洲、中东、南亚及大洋洲和东南亚地区较低(<10/百万人口)。
- 健康信息系统(肾脏登记)可用性有限,急性肾损伤登记仅8个国家(7%),非透析CKD登记仅9个国家(8%)。
- 国际急性肾损伤和CKD指南据报告可及的国家分别为52(45%)和62(52%);发展中国家临床研究能力相对较低。
证据类型、等级与局限
- 证据类型:国际肾脏病学会问卷调查;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,若回复准确反映应答国家肾脏护理状况,调查结果可能有助于为改善全球肾脏护理质量的努力提供信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Kidney disease is a substantial worldwide clinical and public health problem, but information about available care is limited.
OBJECTIVE: To collect information on the current state of readiness, capacity, and competence for the delivery of kidney care across countries and regions of the world.
DESIGN, SETTING, AND PARTICIPANTS: Questionnaire survey administered from May to September 2016 by the International Society of Nephrology (ISN) to 130 ISN-affiliated countries with sampling of key stakeholders (national nephrology society leadership, policy makers, and patient organization representatives) identified by the country and regional nephrology leadership through the ISN.
MAIN OUTCOMES AND MEASURES: Core areas of country capacity and response for kidney care.
RESULTS: Responses were received from 125 of 130 countries (96%), including 289 of 337 individuals (85.8%, with a median of 2 respondents [interquartile range, 1-3]), representing an estimated 93% (6.8 billion) of the world's population of 7.3 billion. There was wide variation in country readiness, capacity, and response in terms of service delivery, financing, workforce, information systems, and leadership and governance. Overall, 119 (95%), 95 (76%), and 94 (75%) countries had facilities for hemodialysis, peritoneal dialysis, and kidney transplantation, respectively. In contrast, 33 (94%), 16 (45%), and 12 (34%) countries in Africa had facilities for hemodialysis, peritoneal dialysis, and kidney transplantation, respectively. For chronic kidney disease (CKD) monitoring in primary care, serum creatinine with estimated glomerular filtration rate and proteinuria measurements were reported as always available in only 21 (18%) and 9 (8%) countries, respectively. Hemodialysis, peritoneal dialysis, and transplantation services were funded publicly and free at the point of care delivery in 50 (42%), 48 (51%), and 46 (49%) countries, respectively. The number of nephrologists was variable and was low (<10 per million population) in Africa, the Middle East, South Asia, and Oceania and South East Asia (OSEA) regions. Health information system (renal registry) availability was limited, particularly for acute kidney injury (8 countries [7%]) and nondialysis CKD (9 countries [8%]). International acute kidney injury and CKD guidelines were reportedly accessible in 52 (45%) and 62 (52%) countries, respectively. There was relatively low capacity for clinical studies in developing nations.
CONCLUSIONS AND RELEVANCE: This survey demonstrated significant interregional and intraregional variability in the current capacity for kidney care across the world, including important gaps in services and workforce. Assuming the responses accurately reflect the status of kidney care in the respondent countries, the findings may be useful to inform efforts to improve the quality of kidney care worldwide.
参考来源
- Bello AK, Levin A, Tonelli M, et al. Assessment of Global Kidney Health Care Status. JAMA. 2017. PMID: 28430830. doi:10.1001/jama.2017.4046
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。